News

SIU Medicine Announces New COVID-19 Testing Times

Published Date:

August 5, 2020 – SIU Medicine, in coordination with the Sangamon County Department of Public Health (SCDPH) and the Office of the Mayor, recently relaunched a testing site at SCDPH to meet the immediate need for expanded testing in Sangamon County. Testing is now available only on select days at 2833 S. Grand Avenue East in the parking area adjacent to the public health building. All testing slots are open during the following times, weather permitting. The site is closed on Wednesdays.

Testing hours are:

  • Monday: 9-11 a.m. | 4-7 p.m.
  • Tuesday: 9-11 a.m. | 4-7 p.m.
  • Thursday: 9-11 a.m. | 4-7 p.m.
  • Friday: 9-11 a.m.

Before heading out for a test, please wait at least four days from a possible exposure to get the most accurate test result and quarantine at home until a result has been given.

The mission of SIU School of Medicine is to optimize the health of the people of central and southern Illinois through education, patient care, research and service to the community. SIU Medicine, the health care practice of the school of medicine, includes clinics and offices with more than 300 providers caring for patients throughout the region.

More from SIU News

healthy foods

SIU Family Medicine offers Diabetes Wellness Workshop on Feb. 11

SIU Center for Family Medicine has been selected as one of only 10 organizations nationwide to participate in the American Diabetes Association’s Obesity Master Trainer program, a designation that
Seed grants, light bulb with seedlings

Small dollars, big discoveries

Fall 2025 SIU Seed Grants have been awarded. These seed grants reflect SIU School of Medicine’s broader commitment to research that matters locally and resonates globally.
Dr. Noor Khalid, abstract achievement award

SIU Medicine fellow’s research finds older cancer patients live longer with chemotherapy

Inspired by patient conversations, Dr. Noor Khalid analyzed 20 years of data to better understand survival outcomes for seniors with blood cancer.